catch wave remain top larg cap
remain top larg cap growth idea follow meeting/sit visit w/
cannabi industri leader canopi growth own came away
impress canopi leadership encourag abil capit
massiv global cannabi opportun reassur confid deliv
scrutin om risk-reward favor w/stz
underli biz trade ev/ebitda well mnst/bfb
intrigu global opportun w/huge tech compani grow
weed came away impress canopi leadership encourag abil
capit massiv global oppt cannabi year follow
recent visit co corp office/manufactur facil smith fall ontario
confid long-term target reassur follow weed miss vs
consensu encourag hear management confid deliv three-
year target compound-annual-growth-rate sale om canada alon
weed continu garner incommensur share investor focu rel
thrive beer segment ebitda management commentari encourag success
patent effect product deliveri mechan materi broader
global oppt medic cannabi cite key guid point weed success
start recreat roll-out canadather understand interest
recreat cannabi busi evolv canada follow legal
oct conclus data management indic roll-out weed
good start ii market share base management best
estim in-lin w/lt guid provid iii retail store
weed product sold store vs though oper
see signific opportun almost doubl penetr rate
recreat use penetr rate cannabi use canada current w/
consumpt heavi user w/oppti increas ii two key
brand tweed mix tokyo smoke higher-end though rounded-out w/
full portfolio brand across price point like mani view target specif
demo need state occas iii year one form across spectrum incl flower pre-rol
oil soft gel iv transform product mix build offer concentr
edibl vape cite recent acquisit storz bikel beverag
cannabi infus beverag big deal new product roll-out importantli
stz sharehold cannabi infus product roll-out still expect calendar
overlap alcohol occas may disrupt light beer appeal women etc
tweed tonic type product sport drink also could tweed brand
myriad opportun outsid canada offer potenti upsid target
us plan two year oppt trend state legal
increasingli clear lot amaz opportun retail perspect ii germani
medic cannabi alon could billion-dollar industri iii poland weed
receiv approv current import market iv brazil like open
market europ mexico malaysia among other note opp
chang estim remain top larg cap growth idea buy
rate predic strong beer growth continu sale growth
ii uniqu exposur burgeon cannabi market weed iii attract
valuat ntm ev/ebitda ex canopi vs three-yr average high
growth beverag peer mnst/bfb initi oversold growth initi
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
chart beer remain key driver
mix growth next year
chart segment outgrown peer due
favor leverag mexican import us
thesi chart
compani report jefferi note base calendar
quarter ii brewer incl abi carl beer
chart stz rel valuat vs stapl shown
strong relationship beer deplet continu
robust growth support stock multipl
chart ebitda margin improv
strong expect moder nonetheless
compani report factset jefferi note price-to-earnings ttm average
ii best-in-class abi na ebitda margin
chart stand benefit increas cannabi
adopt due stake canopi growth corp
chart valuat attract ev/ebitda ex
canopi vs recent average mnst/bfb
factset jefferi assum valu canopi stake/warr
page
pleas see import disclosur inform page report
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
page
pleas see import disclosur inform page report
constel engag product market distribut beer wine spirit oper follow
segment beer wine spirit corpor oper beer segment includ import mexican craft beer brand
wine spirit segment sell wine brand across categori focu premium price point compani found
headquart ny
price target base ev/ebitda ev/ulfcf valuat methodolog ntm estim one year plu present
valu canopi warrant risk forecast includ price ration high-end beer cannabi adopt input cost
deceler mexican import segment
kevin grundi certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
herb eppich cfa certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
case jefferi employe analyst respons coverag financi instrument discuss report receiv
compens base part overal perform firm includ invest bank incom seek updat research
appropri variou regul may prevent us asid certain industri report publish period basi larg major
report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within period
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate secur averag
secur price consist expect total return price appreci plu yield plu minu within period
under-perform rate secur averag secur price consist expect total return price appreci plu yield minu
less within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/
jefferi polici
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic secur regul
prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project opinion
invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil expect total
return next month price target base sever methodolog may includ restrict analys market
premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
page
pleas see import disclosur inform page report
